U.S. flag

An official website of the United States government

NM_000124.4(ERCC6):c.1174G>T (p.Glu392Ter) AND Cockayne syndrome type 2

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Dec 17, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002310215.2

Allele description [Variation Report for NM_000124.4(ERCC6):c.1174G>T (p.Glu392Ter)]

NM_000124.4(ERCC6):c.1174G>T (p.Glu392Ter)

Genes:
ERCC6:ERCC excision repair 6, chromatin remodeling factor [Gene - OMIM - HGNC]
PGBD3:piggyBac transposable element derived 3 [Gene - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q11.23
Genomic location:
Preferred name:
NM_000124.4(ERCC6):c.1174G>T (p.Glu392Ter)
HGVS:
  • NC_000010.11:g.49524256C>A
  • NG_009442.1:g.19846G>T
  • NG_033155.1:g.5026G>T
  • NM_000124.4:c.1174G>TMANE SELECT
  • NM_001277058.2:c.1174G>T
  • NM_001277059.2:c.1174G>T
  • NM_001346440.2:c.1174G>T
  • NM_170753.3:c.-231G>T
  • NP_000115.1:p.Glu392Ter
  • NP_000115.1:p.Glu392Ter
  • NP_001263987.1:p.Glu392Ter
  • NP_001263988.1:p.Glu392Ter
  • NP_001333369.1:p.Glu392Ter
  • LRG_465t1:c.1174G>T
  • LRG_465:g.19846G>T
  • LRG_465p1:p.Glu392Ter
  • NC_000010.10:g.50732302C>A
  • NM_000124.2:c.1174G>T
Protein change:
E392*
Molecular consequence:
  • NM_170753.3:c.-231G>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
  • NM_000124.4:c.1174G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001277058.2:c.1174G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001277059.2:c.1174G>T - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001346440.2:c.1174G>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Cockayne syndrome type 2 (CSB)
Synonyms:
Cockayne syndrome B; Cockayne syndrome type 2; Cockayne Syndrome, Type II
Identifiers:
MONDO: MONDO:0019570; MedGen: C0751038; Orphanet: 191; OMIM: 133540

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002602196Myriad Genetics, Inc.
criteria provided, single submitter

(Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021))		Likely pathogenic
(Dec 17, 2021) 		unknownclinical testing

Citation Link

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Myriad Genetics, Inc., SCV002602196.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

NM_000124.2(ERCC6):c.1174G>T(E392*) is expected to be pathogenic in the context of ERCC6-related disorders. This variant is predicted to lead to an abnormal or absent protein product due to the creation of a premature termination codon in ERCC6, a gene where loss-of-function variants are known to be pathogenic. Please note: this variant was assessed in the context of healthy population screening.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 8, 2024